CPHI Financial Facts

Revenue: 8.25M
Bad debt expense (benefit): -119.93K
See Full Income Statement

Long-term deferred tax liability: 110.29K
Other payables: 1.01M
See Full Balance Sheet

Earnings History for China Pharma Holdings (CPHI)

  |   Expand Research on CPHI
Next EPS Date 8/10/12 *Est. EPS Growth Rate -50.0% *Last Qtr.
Average EPS % Beat Rate 0.0% Revenue Growth Rate -11.0% *Last Qtr.
Average % Move 1-Wk after EPS -1.9%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
5/11/11 Q111 $0.12$0.12 $0.00$18.1M$18M N/A / N/A N/A -90.4% Details
8/11/11 Q211 $0.11$0.11 $0.00$19.6M$19.46M N/A / N/A N/A -88.9% Details
5/15/12 Q112 $0.06N/A N/A $16.1M$18.1M N/A / N/A N/A 0% Details
11/11/11 Q311 $0.08N/A N/A $20.99M$18.68M N/A / N/A N/A 0% Details